Latest News of PODD
Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals
By Yahoo! Finance |
2 days ago
Insulet Corporation (PODD) recently reported strong earnings with a significant tax benefit, raising concerns about sustainability. The one-time benefit may not reflect the company's true earnings pow...
Buy, Sell, Or Hold Insulet (PODD) Stock?
By Forbes |
1 week ago
Insulet's stock soared 10% on strong Q3 results and raised sales outlook due to Omnipod's success. Revenue grew 26% YoY, with a 23% and 36% increase in U.S. and International sales....
Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical Ratings According To Piper Sandler?
By Yahoo! Finance |
1 month ago
Insulet Corporation ranks 6th on Piper Sandler's list of top technical stock picks. Recent market fluctuations driven by economic data and geopolitical tensions have impacted investor sentiment. Analy...
-
Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
By Yahoo! Finance | 1 month agoFidelity Investments' "Fidelity Growth Strategies Fund" Q2 2024 investor letter shows a -2.39% return, slightly outperforming the benchmark. Key holdings like Insulet Corporation (NASDAQ:PODD) gained ...
-
Insulet's (PODD) Sales And Margins Surpassed Expectations
By Yahoo! Finance | 2 months agoBrown Capital Management's Mid Company Fund underperformed in Q2 2024, focusing on EGCs with strong growth. Highlighting Insulet Corporation's success, the fund sees potential in AI stocks for higher ...
-
Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now
By Yahoo! Finance | 3 months agoInsulet Corporation (NASDAQ:PODD) is a key player in the diabetes stock market. Despite inventory concerns, its Omnipod devices show strong demand, leading to increased revenue projections. Analysts s...
-
Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?
By Yahoo! Finance | 4 months agoReturn on Equity (ROE) measures a company's profitability relative to shareholder's equity. Insulet Corporation has an impressive ROE of 30%, surpassing the industry average of 11%. High ROE may be du...
-
Insulet Corporation (PODD) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 4 months agoInsulet Corporation presents positive results from its Omnipod 5 Automated Insulin Delivery System trial at the American Diabetes Association conference. The study assessed the impact of AID in indivi...
-
Insulet (PODD) Faces Increasing Competition
By Yahoo! Finance | 4 months agoClearBridge Investments' Q1 2024 investor letter reported positive momentum in the market with S&P and Russell 3000 Index gains. The ClearBridge Select Strategy underperformed its benchmark....
-
Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field
By Yahoo! Finance | 5 months agoMark Field, CTO of Insulet Corp, sold 1,500 shares at $199.96 each, now owning 12,875 shares. Insulet focuses on insulin delivery systems. Field has sold 3,631 shares in the past year....
-
Insider Sale: Director Timothy Scannell Sells 7,000 Shares of Insulet Corp (PODD)
By Yahoo! Finance | 5 months agoDirector Timothy Scannell of Insulet Corp sold 7,000 shares at $190.51 each, totaling $1,333,570. With 35,586 remaining shares, he has sold 10,300 shares in the past year....